Georgia Healthcare Group PLC Notice of Results (7316N)
May 11 2018 - 1:31AM
UK Regulatory
TIDMGHG
RNS Number : 7316N
Georgia Healthcare Group PLC
11 May 2018
London, 11 May 2018
Georgia Healthcare Group PLC notice of 1Q 2018 Results
Georgia Healthcare Group PLC ("GHG") will publish its financial
results for 1Q 2018 at 07:00 London time on Tuesday, 15 May 2018.
The results announcement will be available on GHG's website at
ghg.com.ge. An investor/analyst conference call, organised by GHG,
will be held on Tuesday, 15 May 2018, at 14:00 UK / 15:00 CET /
09:00 U.S Eastern Time. The duration of the call will be 60 minutes
and will consist of a 15-minute update and a 45-minute Q&A
session.
Dial-in numbers: 30-Day replay
Pass code for replays / conference Pass code for replays /
ID: 1874527 conference ID: 1874527
International Dial in: +44 International Dial in:
(0) 1452 541003 +44 (0) 1452 55 00 00
UK: 08448719461 UK National Dial in: 08717000145
US: 16467412120 UK Local Dial in: 08443386600
Austria: 0316918324 US Free Call Dial in: 1
(866) 247 4222
Belgium: 011500193
Czech Republic: 234099936
Finland: 0923194455
France: 0170700780
Germany: 06922224984
Ireland: 015060638
Italy: 0236005628
Netherlands: 0207168005
Norway: 21563298
Spain: 911142116
Sweden: 0856619445
Switzerland: 0445804282
Name of authorised official of issuer responsible for making
notification:
Ketevan Kalandarishvili, Head of Investor Relations
About Georgia Healthcare Group PLC
Georgia Healthcare Group PLC is a UK incorporated holding
company of the largest healthcare services provider in the
fast-growing, predominantly privately-owned, Georgian healthcare
services market. GHG's leadership position is underpinned by
offering the most comprehensive range of inpatient and outpatient
services targeting the mass market segment through its vertically
integrated network of 37 hospitals and 12 polyclinic clusters
(consisting of 16 polyclinics and 24 express outpatient clinics),
as at 31 December 2017. GHG is the single largest market
participant, accounting for 24.5% of total hospital bed capacity in
the country, as of 31 December 2017. From January 2017, GHG become
the largest pharmaceuticals retailer and wholesaler in Georgia,
with approximately 30% market share by revenue. GHG is the second
largest provider of medical insurance in Georgia with a 29.0%
market share based on net insurance premiums earned and
approximately 155,000 insurance customers as at January 2018. GHG
employed a total of c.15,100 people as at 31 December 2017,
including c.3,500 physicians.
For further information, please visit ghg.com.ge or contact:
Nikoloz Gamkrelidze Irakli Gogia Ketevan Kalandarishvili
CEO CFO Head of Investor
Relations
+995 322 550505 +995 322 550505 +995 322 550505
(5077) (5088) (5079)
ngamkrelidze@ghg.com.ge irakligogia@ghg.com.ge ir@ghg.com.ge
This news report is presented for general informational purposes
only and should not be construed as an offer to sell or the
solicitation of an offer to buy any securities
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORQBLFFVEFEBBL
(END) Dow Jones Newswires
May 11, 2018 02:00 ET (06:00 GMT)
Georgia Healthcare (LSE:GHG)
Historical Stock Chart
From Apr 2024 to May 2024
Georgia Healthcare (LSE:GHG)
Historical Stock Chart
From May 2023 to May 2024